---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-014866"
form_type: "8-K"
ticker: "SIGY"
cik: "0001642159"
company_name: "Sigyn Therapeutics, Inc."
filed_at: "2024-04-16T23:59:59+00:00"
generated_at: "2026-06-03T22:16:30.599931+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Sigyn Therapeutics converts $841k debentures to Series B Preferred; extends other debt to 2025

## Summary
- Brio Capital converts $220,420 debentures into 292.4 shares of Series B Convertible Preferred Stock.
- Osher Capital converts $621,000 debentures into 823.86 shares of Series B Convertible Preferred Stock.
- Each Series B share is convertible into 125.63 common shares, subject to anti-dilution adjustments.
- Brio and Osher amend additional debentures: maturity extended to March 31, 2025; principal increased to $125k and $316,350 respectively.
- Additional automatic conversion of $1,856,566 aggregate debentures into Series B Preferred upon NASDAQ listing.

## SEC filing metadata
- accession: 0001493152-24-014866
- form_type: 8-K
- ticker: SIGY
- cik: 0001642159
- company_name: Sigyn Therapeutics, Inc.
- filed_at: 2024-04-16T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1642159/000149315224014866/0001493152-24-014866-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1642159/000149315224014866/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-014866
- JSON: https://secwatch.observer/filing/0001493152-24-014866.json
- Plain text: https://secwatch.observer/filing/0001493152-24-014866.txt

## Key facts
- Material Agreements
  Sigyn Therapeutics, Inc. amended Debentures with Brio Capital Master Fund Ltd. and Osher Capital Partners, LLC valued at $110,000 and $275,000 (effective 2024-04-10).
  - Action: amendment
  - Agreement: notes offering
  - Counterparty: Brio Capital Master Fund Ltd. and Osher Capital Partners, LLC
  - Value: $110,000 and $275,000
  - Effective: 2024-04-10
  source text: Brio and Osher agreed to amend an additional $110,000 and $275,000, respectively, of Debentures to extend the maturity dates of such Debentures to March 31, 2025 in return for an increase in principal amount of such Debentures to $125,000 and $316,350
  evidence_url: https://www.sec.gov/Archives/edgar/data/1642159/000149315224014866/0001493152-24-014866-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.